• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; PROSTHESIS, PULMONIC VALVE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; PROSTHESIS, PULMONIC VALVE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX26A
Device Problem Malposition of Device (2616)
Patient Problem Insufficient Information (4580)
Event Date 01/05/2023
Event Type  Injury  
Event Description
As reported by the field clinical specialist, during a transfemoral tavr procedure with a 26mm sapien 3 valve in the pulmonic position, the valve deployed too distal in the main pulmonary artery (mpa), causing reduction of flow into the right pulmonary artery (rpa).Per field clinical specialist, the presumed root cause of the malpositioned valve was due to the physician did not hold the device properly.The treatment for the "valve deployed too distal in the mpa" was to bend in a portion of the s3 to allow for both systolic and diastolic flow.The team bent the frame of the s3 inward with a balloon to provide more flow to the rpa.The patient's status post procedure resulted as intended.There was no alleged ew device malfunction/deficiency that caused or contributed to the event.
 
Manufacturer Narrative
The investigation is in progress.A supplemental report will be submitted when additional information is provided.
 
Manufacturer Narrative
A supplemental mdr is being submitted due to engineering evaluation findings.Sections g6, h2, h6: clinical code, device code, type of investigation, investigation findings, investigation conclusions and h10 has been updated.The device was not returned, an imaging evaluation was unable to be performed as no imagery was provided.As no device was returned, engineering was unable to perform visual inspection, functional testing, or dimensional testing.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of this adverse event is not required at this time.The complaint was unable to be confirmed due to unavailable of medical record and relevant imagery.The reported event does not allege a malfunction that could be related to an edwards manufacturing deficiency.Per instructions for use (ifu), valve malposition requiring intervention is a known potential adverse event associated with the transcatheter heart valve (thv) replacement procedure.As reported, "26mm sapien 3 valve in the pulmonic position, the valve deployed too distal in the main pulmonary artery (mpa), causing reduction of flow into the right pulmonary artery (rpa)".In this case, the root cause was presumed to me "due to the physician did not hold the device properly".As such, available information suggests that procedural factors (valve position and deployment technique) may have contributed to the complaint event.The ifu and training manuals have been reviewed and no labeling/ifu deficiencies were identified, no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No device problem or manufacturing non-conformance that would have contributed to the complaint event was identified during the evaluation.Therefore, no corrective or preventative actions nor product risk assessment escalation is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
PROSTHESIS, PULMONIC VALVE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16224586
MDR Text Key307910849
Report Number2015691-2023-10309
Device Sequence Number1
Product Code NPV
UDI-Device Identifier00690103194357
UDI-Public(01)00690103194357(17)251023
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P200015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/23/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9600TFX26A
Device Catalogue Number9600TFX26A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-